Prognostic and clinical value of Targeting protein for Xenopus kinesin-like protein 2 in patients with gastrointestinal tract cancers: A meta-analysis.

The pooled results showed a strong trend, but no significant difference was observed between TPX2 protein expression level and MFS in GI tract cancers (HR: 3.25; 95% CI: 0.99–5.51), and there was no significant heterogeneity across studies (I 2 = 0.0%, P Q = .697; fixed-effect model) (Fig. 3 ). 3.2.3 TPX2 over-expression and clinicopathological factors in GC There were only 3 studies [ 16 – 18 ] exploring the relationship between TPX2 level and clinicopathological features of GC. 3 studies were assessed the correlation between TPX2 expression and gender, lymph node metastasis (LNM) and tumor stage.

also in 5,725 other papers